Investor update
Logotype for Bayer AG

Bayer (BAYN) Investor update summary

Event summary combining transcript, slides, and related documents.

Logotype for Bayer AG

Investor update summary

13 Apr, 2026

Strategic rationale and settlement overview

  • Announced a class settlement agreement to resolve current and future U.S. glyphosate/Roundup litigation, pending court approval, with capped annual payments over up to 21 years.

  • The settlement aims to provide speed and closure, freeing resources for core business innovation and reducing litigation uncertainty.

  • Supreme Court review of the Durnell case is critical, as a favorable decision could address cases not covered by the settlement and provide regulatory clarity.

  • The agreement is supported by leading plaintiff law firms and covers those exposed to Roundup before February 17, 2026, with NHL diagnosis within 16 years after settlement effectiveness.

  • Separate confidential settlements reached for other Roundup and PCB cases, including environmental cases in Illinois and West Virginia.

Financial impact and funding

  • Litigation provisions and liabilities increased from EUR 7.8 billion to EUR 11.8 billion, with about EUR 9.6 billion for glyphosate and EUR 1.9 billion for PCB cases.

  • Funding for the class settlement will total up to $7.25 billion, paid in declining capped annual payments over up to 21 years, with the largest annual payments in 2026 and subsequent annual payments around EUR 1 billion for five years, then declining.

  • Immediate financing secured with an $8 billion bank loan facility; long-term plan involves senior bonds and equity-credit instruments, with no current plans to use authorized capital increase.

  • Provisions include all known settlements, verdicts, and litigation costs to date.

  • Settlements are tax deductible in the U.S., with an effective tax rate expected to remain within 24%-26%.

Legal process and next steps

  • Settlement requires preliminary and final court approval, with a robust notice and opt-out process for class members.

  • Supreme Court hearing scheduled for April 27th; outcome could influence unresolved cases and opt-outs.

  • If opt-outs are excessive, Monsanto can terminate the settlement without payment.

  • The class settlement is structured as a long-term compensation program, managed by a professional claims administrator.

  • Only NHL claims are covered; other conditions are not included in the release.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more